Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 816 results for "Treatment For Ovarian Cancer"

Discovery of 2 genes that modulate risk of breast and ovarian cancer
EHealth Magazine

Discovery of 2 genes that modulate risk of breast and ovarian ...

Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. EHealth Magazine, 1 week ago
[x]  

55 images for Treatment For Ovarian Cancer

InToday, 1 week ago
Nasdaq, 2 weeks ago
MedIndia, 3 weeks ago
Vancouver 24 Hours, 3 weeks ago
Inside INdiana Business, 4 weeks ago
ABC15.com, 3 weeks ago
Science Daily, 3 weeks ago
Northern Territory News, 2 months ago
Proactive Investors Australia, 1 month ago
PitchEngine, 1 month ago

Novocure To Present New Pre-Clinical Data On NovoTTFa¢ Therapy At The American Association For Cancer Research Annual Meeting 2014

HAIFA, Israel The new study results show that ovarian cancer cells treated with Tumor Treating Fields (TTFields) exhibit abnormal chromosomal separation during cell division, reducing the viability of surviving daughter cells and inhibiting the ...
 TheStreet.com2 weeks ago NovoCure Ltd. To Present New Pre-Clinical Data On NovoTTF Therapy At American Association for Cancer Research Annual Meeting 2014  BioSpace2 weeks ago
[x]  

Critical Outcome Technologies Reports Application for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer

(Close-Up Media via COMTEX News Network) -- Critical Outcome Technologies, a bioinformatics and accelerated drug discovery company, announced it has submitted an Orphan Drug Application to the U.S. Food and Drug Administration (FDA) for its lead ...
 PredictWallStreet1 week ago Critical Outcome seeks FDA orphan drug status for ovarian cancer drug COTI-2  Pharmaceutical Technology1 week ago
Nasdaq

Sorrento to Present Data on Cynviloq-Abraxane PK Study for Ovarian Cancer

Sorrento Therapeutics, Inc. (Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, announced today that it will present data on the comparison of Cynviloq and Abraxane ® (nab-paclitaxel) ...
 Azonano1 week ago Sorrento Therapeutics Announces Key Presentation on Cynviloq at the American Association for Cancer Research Annual Meeting  Asian Hospital & Healthcare Management1 week ago Sorrento Therapeutics, Inc. Announces Key Presentation On Cynviloq At The American Association for Cancer Research Annual Meeting  BioSpace2 weeks ago
[x]  
Med India

Injecting vitamin C may help fight cancer

The vitamin could potentially be a safe, effective and low-cost treatment for ovarian and other cancers, Press Trust of India | London February 10, 2014 Last Updated at 15:23 IST Injecting large doses of vitamin C may boost chemotherapy's ability to kill ...
 Business Standard2 months ago Vitamin C can help fight cancer, says study  Jagran Post2 months ago Injecting Vitamin C Could Keep Cancer at Bay: Research  Med India2 months ago Vitamin C jab may help fight cancer  Business Standard2 months ago
Nasdaq

CRITICAL OUTCOME TECHNOLOGIES : Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer

) - Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE:COT), the bioinformatics and accelerated drug discovery company, announced today it has submitted an Orphan Drug Application to the U.S. Food and Drug Administration (FDA) ...
 4 Traders2 weeks ago Critical Outcome Technologies applies for orphan drug designation for COTI-2 treatment of ovarian cancer  Reuters UK2 weeks ago
[x]  

Research yields potential target for epithelial ovarian cancer treatment

The page you are looking for has moved. Please go to the main EurekAlert! homepage to locate the section you are interested in and reset your bookmarks. If you are looking for this week's current news releases, click on "Breaking News" once you ...
 EurekAlert!1 week ago Potential target for epithelial ovarian cancer treatment identified  Science Daily1 week ago

Forum Post: how do you deal with a loved one.who doesnt want treatment

My mom gas had bowel cancer and ovarian cancer hasnt really dealt with this she didnt get all treatment has no confidence in medical profession 4 years on she.is no better mentally she has had a breskdown and cant deāk with anything now pushee ...
 Macmillan Cancer Support2 weeks ago

Caprion To Present Immune Response Results From Phase 1 Study In Ovarian Cancer Patients At 2014 American Association for Cancer Research Annual Meeting

Multiparametric flow cytometry has proven to be the tool of choice for immune profiling in cancer patients following treatment with a vaccine and an immune modulating drug Montreal, Canada - April 3, 2014—Caprion, announced today that its immune ...
 BioSpace2 weeks ago
NDTV

Manisha Koirala: Fear recurrence of cancer, but have to be positive

Actress Manisha Koirala, who was earlier diagnosed with ovarian cancer and has now recovered, says there is always a fear the disease may recur but she believes in being positive in life. "I did not take care of my health earlier. I was not looking ...
 NDTV2 weeks ago I love life more: Manisha Koirala  InToday1 week ago Tough days opened my eyes: Manisha Koirala  InToday1 week ago Manisha Koirala Fights Cancer With Courage And Wants To Act Again  BusinessofCinema.com2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less